表紙画像

The analysis of characteristics of anti-SARS-CoV-2 antibodies in clinically COVID-19 patients

<p>Background: The novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had spread all of China and many other countries. The COVID-19 patients exhibit typical clinical symptoms, and most cases could be diagnosed by nucleic acid testing...

保存先:

書誌詳細
主要な著者:	Wenzheng Guo (著者), Siyuan Yu (著者), Guangbo Li (著者), Qiankun Xuan (著者), Simin Yang (著者), Donghua Wen (著者), Wenjuan Wu (著者)
フォーマット:	図書
出版事項:	Journal of Clinical Research and Ophthalmology - Peertechz Publications, 2020-07-31.
主題:	Research Article
オンライン･アクセス:	Connect to this object online.
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
著者:: Liu T, 等
出版事項: (2021)

High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad
著者:: Andrillene Laure Deutou Wondeu, 等
出版事項: (2022)

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
著者:: Marco Tuccori, 等
出版事項: (2020)

Anti-SARS-CoV-2 antibodies important in diagnostics of acute hepatitis in children
著者:: Małgorzata Pawłowska, 等
出版事項: (2023)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
著者:: Romain Rouet, 等
出版事項: (2021)

Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2
著者:: Ruth Connor, 等
出版事項: (2024)

Can anti-TNFα Antibodies Affect SARS-CoV-2 Disease Outcomes?
著者:: Mohammad Reza Khazdair
出版事項: (2022)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
著者:: Shinta Oktya Wardhani, 等
出版事項: (2021)

Dynamic Changes of Antibodies to SARS-CoV-2 in Close Contacts
著者:: Yao J, 等
出版事項: (2021)

Waning antibodies to SARS-CoV-2 - Don't panic
著者:: Benjamin Meyer
出版事項: (2021)

Neutralizing and enhancing antibodies against SARS-CoV-2
著者:: Yafei Liu, 等
出版事項: (2022)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
著者:: Surjeet Verma, 等
出版事項: (2020)

Anti-SARS-CoV-2-specific antibodies in human breast milk following SARS-CoV-2 infection during pregnancy: a prospective cohort study
著者:: Irene Fernández-Buhigas, 等
出版事項: (2024)

Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
著者:: Wen Jiang, 等
出版事項: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study
著者:: Marcela Mercado-Reyes, 等
出版事項: (2022)

Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients
著者:: Hongye Wang, 等
出版事項: (2022)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
著者:: Wu Zhong, 等
出版事項: (2022)

Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain
著者:: Ping-Han Huang, 等
出版事項: (2021)

Genomic and epidemiological characteristics of SARS-CoV-2 in Africa.
著者:: Jones Lamptey, 等
出版事項: (2021)

Molnupiravir-A Novel Oral Anti-SARS-CoV-2 Agent
著者:: Ching-Chi Lee, 等
出版事項: (2021)

Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers
著者:: Amit Bansal, 等
出版事項: (2023)

Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection
著者:: Lorenza Romani, 等
出版事項: (2022)

SARS-CoV-2 Antibody Response to Vaccination in Peritoneal Dialysis Patients
著者:: Beatriz Donato, 等
出版事項: (2023)

Potential Anti-SARS-CoV-2 Molecular Strategies
出版事項: (2023)

Temporal profile of specific antibody against SARS-CoV-2 among infected people: a literature study
著者:: Wen WU, 等
出版事項: (2022)

Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
著者:: Wu Zhong, 等
出版事項: (2022)

Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response
著者:: Marc-Kendy Paul, 等
出版事項: (2024)

SARS-CoV-2 anti-N antibodies among healthcare personnel without previous known COVID-19
著者:: Sajal Tiwary, 等
出版事項: (2024)

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
著者:: Marie Kroemer, 等
出版事項: (2022)

Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines
著者:: Ziyu Liu, 等
出版事項: (2024)

Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients
著者:: Hsiang-Ling Ho, 等
出版事項: (2020)

Genomic characteristics of SARS-CoV-2 in Beijing, China, 2021
著者:: Zhaomin Feng, 等
出版事項: (2022)

Clinical characteristics of children infected with SARS-CoV-2 in Italy
著者:: Isabella Tarissi De Jacobis, 等
出版事項: (2021)

Genome evolution of SARS-CoV-2 and its virological characteristics
著者:: So Nakagawa, 等
出版事項: (2020)

Clinical characteristics and clinical outcome of community clusters with SARS-CoV-2 infection
著者:: Xueling Zhu, 等
出版事項: (2023)

Prevalence and persistence of SARS-CoV2 antibodies among healthcare workers in Oman
著者:: Khalid Al-Naamani, 等
出版事項: (2021)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
著者:: Xingsu Gao, 等
出版事項: (2022)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
著者:: Khan Sharun, 等
出版事項: (2021)

Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein
著者:: Curtis D. Hodge, 等
出版事項: (2021)

Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
著者:: Eugenia Quiros-Roldan, 等
出版事項: (2021)